Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Krsnaa DiagnosticsNSE:KRSNAA +0.02%68 Owner Earnings per Share (TTM) is 18.71 as of Mar. 2026. GuruFocus rates NSE:KRSNAA with a GF Score™ of 68/100 and a GF Value™ of ₹928.59 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 73 Medical Diagnostics & Research companies, Krsnaa Diagnostics ranks worse than 54.79% on this metric.
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Krsnaa Diagnostics does not have enough data to calculate Owner Earnings per Share (TTM), so as Price-to-Owner-Earnings ratio.
The historical rank and industry rank for Krsnaa Diagnostics's Owner Earnings per Share (TTM) or its related term are showing as below:
NSE:KRSNAA'
s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 28.31 Med: 322.92 Max: 460.61
Current: 29.4
NSE:KRSNAA's Price-to-Owner-Earnings is ranked worse than 54.79% of 73
companies
in the Medical Diagnostics & Research industry
Industry Median: 25.74
vs NSE:KRSNAA: 29.40
Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.
Note: GuruFocus' Change In Working Capital is provided by FactSet. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.
Krsnaa Diagnostics Owner Earnings per Share (TTM) Related Terms
Krsnaa Diagnostics Owner Earnings per Share (TTM) Historical Data
* Premium members only.
The historical data trend for Krsnaa Diagnostics's Owner Earnings per Share (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Krsnaa Diagnostics Owner Earnings per Share (TTM) Chart
NSE:KRSNAA vs TMO, DHR, NTRA: Owner Earnings per Share (TTM) Comparison
For the Diagnostics & Research subindustry, Krsnaa Diagnostics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Krsnaa Diagnostics Price-to-Owner-Earnings vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Krsnaa Diagnostics's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Krsnaa Diagnostics's Price-to-Owner-Earnings falls into.
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
What does a Owner Earnings per Share (TTM) of 18.71 mean?
Krsnaa Diagnostics (NSE:KRSNAA) has a Owner Earnings per Share (TTM) of 18.71 as of Mar. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Krsnaa Diagnostics. According to the industry distribution chart, Krsnaa Diagnostics ranks #40 out of 73 companies in the Medical Diagnostics & Research industry, placing it in the top 54.8%.
Is Krsnaa Diagnostics' Owner Earnings per Share (TTM) too high?
Krsnaa Diagnostics' current Owner Earnings per Share (TTM) is 18.71. The Medical Diagnostics & Research industry median Owner Earnings per Share (TTM) is 25.74. Krsnaa Diagnostics' value of 18.71 is 27.3% below this industry median. Based on the distribution chart, Krsnaa Diagnostics ranks #40 out of 73 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Krsnaa Diagnostics has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Krsnaa Diagnostics' Owner Earnings per Share (TTM) compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Krsnaa Diagnostics ranks #40 out of 73 companies for Owner Earnings per Share (TTM). This places Krsnaa Diagnostics in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 25.74. Krsnaa Diagnostics' value of 18.71 is 27.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Medical Diagnostics & Research company?
The median Owner Earnings per Share (TTM) among Medical Diagnostics & Research companies is 25.74, based on 73 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Krsnaa Diagnostics's current Owner Earnings per Share (TTM) of 18.71 is 27.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Krsnaa Diagnostics. For the Medical Diagnostics & Research industry, the median Owner Earnings per Share (TTM) is 25.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Krsnaa Diagnostics's current Owner Earnings per Share (TTM) is 18.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krsnaa Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Krsnaa Diagnostics (NSE:KRSNAA) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹928.59, compared to a current price of ₹541.15 — trading 41.7% below its estimated fair value. The current Owner Earnings per Share (TTM) is 18.71 and 27.3% below the Medical Diagnostics & Research industry median of 25.74. Krsnaa Diagnostics' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Krsnaa Diagnostics (NSE:KRSNAA), the current Owner Earnings per Share (TTM) is 18.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Krsnaa Diagnostics (NSE:KRSNAA) Overvalued in 2026?
Based on GuruFocus' analysis, Krsnaa Diagnostics stock appears to be undervalued.
The current stock price of ₹541.15 is trading 41.7% below its estimated GF Value™ of ₹928.59.
GuruFocus considers Krsnaa Diagnostics to be Significantly Undervalued.
Key valuation signals for NSE:KRSNAA:
Owner Earnings per Share (TTM): 18.71
GF Value™: ₹928.59 vs. price of ₹541.15 (41.7% below fair value)
Industry Position: 27.3% below the Medical Diagnostics & Research median (#40 of 73)
No single metric tells the full story. See the NSE:KRSNAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Krsnaa Diagnostics Ltd is a diagnostic services provider, both in Radiology and Pathology. It offers a wide range of diagnostic services such as imaging/radiology services, routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres. The company's operations predominantly relate to providing Radiology and Pathology services for X Ray, CT Scan, MRI, Mammography, tele-reporting services, and all types of Blood and Urine investigations.
68GF Score
Get the complete analysis for NSE:KRSNAA
Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:KRSNAA has been successfully added to your 
